Cite
HARVARD Citation
Ntanasis-Stathopoulos, I. et al. (2022). Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals. HemaSphere. 6 (7), pp. e747-. [Online].